This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.
The EBMT Scientific Council, together with the local organising committee, has designed an outstanding programme to cover key issues relating to HSCT and cellular therapy research. The programme is made up of more than 170 sessions and 300 speakers.
This meeting will be focused on the theme “Bridging the gap between the patient and the product design”. The aim of the Annual meeting is to bring together people from all over the world who are involved in pharmaceutical sciences in order to exchange the latest results, experiences, and information and to build communication and collaboration at regional and global scales in a friendly spirit.